Skip to main content

LadRx Corp

LADXDelisted
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0000799698

LadRx Corp was delisted in 2025; its insiders filed their last Form 4 on Jan 29, 2024; no institution reported holding it in 13F filings for Q3 2025; no superinvestor held it.

Q1 2023 vs. Q4 2022

How the institutions holding LadRx Corp changed between Q4 2022 and Q1 2023.

All holders in Q1 2023All holders in Q4 2022

13F holders of LADX: Q4 2022 compared with Q1 2023
MeasureQ4 2022Q1 2023Change
Holders10−1
Shares1.00K0−1.00K (−100.0%)
Value$115$0−$115 (−100.0%)

New holders (0)

Institutions that held LadRx Corp at the end of Q1 2023 but not at the end of Q4 2022.

None.

Sold out (1)

Institutions that held LadRx Corp at the end of Q4 2022 and filed for Q1 2023 without it.

Institutions that sold out of LADX in Q1 2023
InstitutionShares, Q4 2022Value, Q4 2022
Archer Investment Corp1,000$115